Caleres Inc CAL
We take great care to ensure that the data presented and summarized in this overview for CALERES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CAL
View all-
Black Rock Inc. New York, NY5.41MShares$93.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.22MShares$55.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$35.5 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.72MShares$29.8 Million0.02% of portfolio
-
State Street Corp Boston, MA1.6MShares$27.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.15MShares$19.9 Million0.02% of portfolio
-
Neuberger Berman Group LLC New York, NY893KShares$15.5 Million0.02% of portfolio
-
Royce & Associates LP804KShares$13.9 Million0.18% of portfolio
-
Nokomis Capital, L.L.C. Dallas, TX792KShares$13.7 Million7.98% of portfolio
-
Geode Capital Management, LLC Boston, MA789KShares$13.7 Million0.0% of portfolio
Latest Institutional Activity in CAL
Top Purchases
Top Sells
About CAL
Caleres, Inc. engages in the retail and wholesale of footwear in the United States, Canada, China, and Guam. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products to women, men, and children. Its retail shoe stores provide brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Converse, Crocs, Puma, Birkenstock, New Balance, Asics, New Balance, Under Armour, Bearpaw, Timberland, Sperry, and Dr. Martens, as well as company-owned and licensed brands, such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Zodiac, Circus by Sam Edelman, Franco Sarto, and Ryka. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, allenedmonds.com, drschollsshoes.com, lifestride.com, francosarto.com, ryka.com, bzees.com, and zodiacshoes.com, as well as Vince.com, blowfishshoes.com, and veronicabeard.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalogs. Further, the company wholesales men's apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear under the Bzees brand; other footwear under Zodiac brand; and women's footwear collection under Veronica Beard brand, as well as Via Spiga brand. It operates approximately 980 retail stores. The company was formerly known as Brown Shoe Company, Inc. Caleres, Inc. was founded in 1878 and is headquartered in St. Louis, Missouri.
Insider Transactions at CAL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 27
2025
|
Lori Greeley Director |
BUY
Open market or private purchase
|
Direct |
9,000
+21.04%
|
$153,000
$17.75 P/Share
|
Mar 24
2025
|
John W Schmidt President & CEO, Caleres |
BUY
Grant, award, or other acquisition
|
Direct |
145,519
+24.61%
|
-
|
Mar 24
2025
|
Willis Hill Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,066
+21.62%
|
-
|
Mar 24
2025
|
Todd E Hasty SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,372
+22.94%
|
-
|
Mar 24
2025
|
Daniel R Freidman Chief Sourcing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,463
+18.39%
|
-
|
Mar 24
2025
|
Jack Calandra SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,776
+28.24%
|
-
|
Mar 24
2025
|
Michael R Edwards Div President, Famous Footwear |
BUY
Grant, award, or other acquisition
|
Direct |
26,776
+18.26%
|
-
|
Mar 24
2025
|
Thomas C Burke SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,727
+18.24%
|
-
|
Mar 17
2025
|
Diane M Sullivan Executive Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
48,818
-32.45%
|
$781,088
$16.1 P/Share
|
Mar 17
2025
|
Willis Hill Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,642
-5.9%
|
$42,272
$16.1 P/Share
|
Mar 17
2025
|
John W Schmidt President & CEO, Caleres |
SELL
Payment of exercise price or tax liability
|
Direct |
11,655
-3.74%
|
$186,480
$16.1 P/Share
|
Mar 17
2025
|
Daniel R Freidman Chief Sourcing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,982
-3.2%
|
$31,712
$16.1 P/Share
|
Mar 17
2025
|
Todd E Hasty SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,155
-4.96%
|
$18,480
$16.1 P/Share
|
Mar 17
2025
|
Michael R Edwards Div President, Famous Footwear |
SELL
Payment of exercise price or tax liability
|
Direct |
5,381
-5.46%
|
$86,096
$16.1 P/Share
|
Mar 17
2025
|
Thomas C Burke SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,440
-2.73%
|
$23,040
$16.1 P/Share
|
Mar 16
2025
|
Willis Hill Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,817
-5.92%
|
$42,255
$15.41 P/Share
|
Mar 16
2025
|
John W Schmidt President & CEO, Caleres |
SELL
Payment of exercise price or tax liability
|
Direct |
22,405
-6.7%
|
$336,075
$15.41 P/Share
|
Mar 16
2025
|
Daniel R Freidman Chief Sourcing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,165
-3.37%
|
$32,475
$15.41 P/Share
|
Mar 16
2025
|
Todd E Hasty SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-4.89%
|
$17,940
$15.41 P/Share
|
Mar 16
2025
|
Michael R Edwards Div President, Famous Footwear |
SELL
Payment of exercise price or tax liability
|
Direct |
4,382
-4.26%
|
$65,730
$15.41 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 272K shares |
---|---|
Exercise of conversion of derivative security | 10.7K shares |
Open market or private purchase | 14K shares |
Payment of exercise price or tax liability | 146K shares |
---|---|
Open market or private sale | 164K shares |